ISRG vs MSFT: Which Is the Better Buy?
Side-by-side comparison of Intuitive Surgical, Inc. and Microsoft Corporation β fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-16.
Intuitive Surgical, Inc. Β· Healthcare
$388.97
+45.0% upside to fair value
Grade B
High Quality
VS
Microsoft Corporation Β· Technology
$379.40
+45.0% upside to fair value
Grade A
High Quality
QuantHub Verdict
MSFT trades at a lower forward P/E
(22.5x).
These are model outputs β not personalized investment advice.
See all research β
Valuation & Fundamentals
| Metric |
ISRG |
MSFT |
| Current Price |
$388.97 |
$379.40 |
| Fair Value Estimate |
$564.01 |
$550.13 |
| Upside to Fair Value |
+45.0%
|
+45.0%
|
| Market Cap |
$137.8B |
$2,818.3B |
| Forward P/E |
46.5x
|
22.5x
|
| EV / EBITDA |
31.4x
|
14.2x
|
| Price / Sales |
13.0x
|
8.9x
|
| Price / FCF |
48.6x
|
38.6x
|
| Revenue Growth YoY |
+23.0%
|
+18.3%
|
| Gross Margin |
66.3%
|
68.3%
|
| Operating Margin |
30.5%
|
46.8%
|
| Return on Equity |
17.0%
|
33.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.06%
|
2.59%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Intuitive Surgical, Inc. operates in the healthcare sector, specializing in medical devices with a strong focus on robotic-assisted surgery systems. The company demonstrates high business quality with a durable competitive moat supported by a 17.0% return on equity, robust gross margin of 66.3%, and solid operating margin of 30.5%. Revenue and earnings growth in the most recent quarter were impreβ¦
Microsoft Corporation is a leading global technology company specializing in cloud computing, productivity software, and enterprise platforms. The company benefits from a very strong and widening competitive moat supported by scale, switching costs, an integrated ecosystem, and disciplined capital allocation including large buybacks and dividends. Its business quality is high, demonstrated by a 3β¦
Accumulation Zones
| Metric |
ISRG |
MSFT |
| Zone Low |
$423.01 |
$412.60 |
| Zone High |
$479.41 |
$467.61 |
| In Buy Zone? |
Yes
|
Yes
|